National Survey of Research Commercialisation - Australian ...

More documents

Recommendations

Info

Table 13: Gross income from licences — running royalties, cashed-in equity and all other income, Year 2000 ($’000) (for respondents that provided data) COMMERCIAL ACTIVIT Y Total Gross Income Running Royalties Percent of Total Cashed-In Equity Percent of Total All Other Income Universities 79,834 8,702 11 52,342 66 18,790 24 Medical Research Institutes 8,071 4,002 50 2,200 27 1,869 23 CSIRO 11,620 5,455 47 600 5 5,565 48 Total 99,525 18,159 18 55,142 55 26,224 26 Percent of Total CSIRO reported that, of the 220 of its licences which yielded income in Year 2000, 170 yielded income in the form of running royalties and one yielded income in the form of cashed-in equity. All others yielded income from other sources, such as licence-issue fees, payments under options and termination payments. Of CSIRO’s 220 income producing-licences, six accounted for 55% of total gross income from licences — 21% of income-producing licences accounted for almost 90% of total gross income from licences. Some 38% ($4.4 million) of gross income from licences was from overseas. C) INCOME FROM LICENCES VERSUS PROGRAM AGE The survey sought information about the year in which institutions first dedicated at least one half-time personnel to commercialisation activities. This information allows an examination to be made of the degree of correlation between an institution’s income from licences and that institution’s length of experience managing commercial licensing activities. The graph below groups the licensing programs of individual universities and medical research institutes according to the income they yielded in Year 2000 and their age (which indicates length of experience managing commercial licences). An institution’s licensing program is the set of all of the commercialisation activities associated with its licences. Number of programs by income and program age 33
NATIONAL SURVEY OF RESEARCH COMMERCIALISATION There appears to be a positive relationship between an institution’s income from licences and that institution’s length of experience managing commercial licensing activities: Four of the five licensing programs that yielded income of more than $3 million in Year 2000 had been in operation for ten or more years. Of the licensing programs that yielded income of less than $1 million in Year 2000, 68% had been in operation for less than ten years. D) INVENTOR INVOLVEMENT IN LICENSING The survey sought information from institutions about the degree of inventor involvement in the commercialisation of each of their licences. Table 14: Inventor involvement in licensing, Year 2000 (for respondents that provided data) Total Number of Licences Inventor Extremely Involved Inventor Very Involved Inventor Moderately Involved Inventor Somewhat Involved Inventor Uninvolved Universities 232 87 90 24 24 7 Medical Research Institutes 15 11 3 1 0 0 CSIRO 168 62 51 16 26 13 Total 415 160 144 41 50 20 Inventor involvement in licensing Inventor involvement appears to be an important element of the strategies employed by universities, medical research institutes and CSIRO to manage their commercial licensing activities: In 73% of cases, inventors were either extremely involved or very involved in licensing activities. In only 5% of cases were inventors uninvolved in licensing activities. 34
Page 2 and 3: NATIONAL SURVEY OF RESEARCH COMMERC
Page 4: FOREWORD This report presents findi
Page 22 and 23: 2. COMMERCIAL ACTIVIT Y — THE SUR
Page 24 and 25: RESEARCH EXPENDITURE COMMERCIAL ACT
Page 26 and 27: INVENTION DISCLOSURES AND PATENTS C
Page 28 and 29: applications filed by a single univ
Page 30 and 31: LICENCES COMMERCIAL ACTIVIT Y The t
Page 32 and 33: Table 11: Licences executed — to
Page 36 and 37: E) RESEARCH AREAS FROM WHICH LICENC
Page 38 and 39: B) OPERATIONAL STATUS COMMERCIAL AC
Page 40 and 41: 3. COUNTRY COMPARISONS INTRODUCTION
Page 42 and 43: FINDINGS FROM THE COUNTRY COMPARISO
Page 44 and 45: 4. CONCLUSIONS There is a long-held
Page 46: and Innovation Council (PMSEIC) in
Page 67 and 68: XENOME The same chemical compounds
Page 70 and 71: APPENDIXES 1. SURVEY RESPONDENTS 2.
Page 72 and 73: APPENDIX 2—SURVEY QUESTIONNAIRE T
Page 74 and 75: 73
Page 76 and 77: 75
Page 78 and 79: 77
Page 80 and 81: 79
Page 82 and 83: 81
Page 84 and 85:
APPENDIX 3— EXPLANATORY MEMORANDU
Page 86 and 87:
85
Page 88 and 89:
87
Page 90 and 91:
89
Page 92 and 93:
APPENDIX 4—TABLES TABLE A1. COMME
Page 94 and 95:
93
Page 96 and 97:
95
Page 98 and 99:
97
Page 100 and 101:
99
Page 102 and 103:
101
Page 104 and 105:
103
Page 106 and 107:
105
Page 108 and 109:
107
Page 110 and 111:
continued on next page 109
Page 112 and 113:
111
Page 114 and 115:
APPENDIX 5 START-UP COMPANIES FORME
show all

National Survey of Research Commercialisation - Australian ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?